Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 18, 2023

SELL
$4.78 - $15.01 $23,661 - $74,299
-4,950 Reduced 18.57%
21,705 $0
Q3 2022

Oct 14, 2022

SELL
$10.22 - $23.7 $10,220 - $23,700
-1,000 Reduced 3.62%
26,655 $307,000
Q2 2022

Jul 13, 2022

BUY
$4.35 - $15.85 $120,299 - $438,331
27,655 New
27,655 $313,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $46.5M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.